US Stock MarketDetailed Quotes
TLX Telix Pharmaceuticals
- 15.490
- -0.330-2.09%
Close Dec 23 16:00 ET
5.18BMarket Cap178.05P/E (TTM)
17.293High15.400Low7.47KVolume15.800Open15.820Pre Close118.60KTurnover0.04%Turnover Ratio1721.11P/E (Static)334.72MShares19.99052wk High21.57P/B263.33MFloat Cap14.44052wk Low--Dividend TTM17.00MShs Float19.990Historical High--Div YieldTTM11.97%Amplitude14.440Historical Low15.883Avg Price1Lot Size
Telix Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (FY)Dec 30, 2023 | (FY)Dec 30, 2022 | (FY)Dec 30, 2021 | (FY)Dec 30, 2020 | (FY)Dec 30, 2019 | (FY)Dec 30, 2018 | (FY)Dec 30, 2017 | |
|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | |||||||
| Cash flow from continuing operating activities | |||||||
| Cash from discontinued investing activities | |||||||
| Investing cash flow | |||||||
| Cash flow from continuing investing activities | -49.96%-25.49M | -523.51%-17M | -149.86%-2.73M | -133.12%-1.09M | 82.62%-468K | -213,640.08%-2.69M | -1.26K |
| Net PPE purchase and sale | -37.52%-9.68M | -425.62%-7.04M | -439.92%-1.34M | 38.46%-248K | ---403K | ---- | ---5.64K |
| Net intangibles purchase and sale | 83.66%-1.12M | ---6.82M | ---- | -13.85%-74K | ---65K | ---- | ---- |
| Net business purchase and sale | ---- | ---973K | ---- | ---322K | ---- | -61,558.81%-2.69M | --4.38K |
| Net investment purchase and sale | ---13.16M | ---- | ---- | ---- | ---- | ---- | ---- |
| Net other investing changes | 28.80%-1.54M | -55.95%-2.16M | -210.29%-1.39M | ---447K | ---- | ---- | ---- |
| Cash from discontinued investing activities | |||||||
| Investing cash flow | -49.96%-25.49M | -523.51%-17M | -149.86%-2.73M | -133.12%-1.09M | 82.62%-468K | -213,640.08%-2.69M | ---1.26K |
| Financing cash flow | |||||||
| Cash flow from continuing financing activities | -94.18%10.19M | 6,047.58%174.96M | -91.66%2.85M | -20.14%34.12M | 5,014.34%42.72M | -101.59%-869.35K | 54.79M |
| Net issuance payments of debt | 91.80%5.76M | 982.65%3M | 15.42%-340K | 57.37%-402K | -8.47%-943K | -13.02%-869.35K | ---769.18K |
| Net common stock issuance | -96.16%6.65M | 4,480.20%173.22M | -89.20%3.78M | -22.61%35.02M | --45.25M | ---- | --55.56M |
| Net other financing activities | -75.79%-2.22M | -112.08%-1.26M | -18.73%-596K | 68.39%-502K | ---1.59M | ---- | ---- |
| Cash from discontinued financing activities | |||||||
| Financing cash flow | -94.18%10.19M | 6,047.58%174.96M | -91.66%2.85M | -20.14%34.12M | 5,014.34%42.72M | -101.59%-869.35K | --54.79M |
| Net cash flow | |||||||
| Beginning cash position | 427.88%116.33M | -71.73%22.04M | 74.77%77.95M | 73.05%44.6M | -47.15%25.77M | --48.76M | ---- |
| Current changes in cash | -90.87%8.58M | 258.75%93.99M | -269.23%-59.21M | 84.90%34.99M | 177.83%18.92M | -149.86%-24.31M | --48.76M |
| Effect of exchange rate changes | -659.53%-1.67M | -90.94%299K | 301.34%3.3M | -1,625.26%-1.64M | -107.18%-95K | --1.32M | ---- |
| End cash Position | 5.94%123.24M | 427.88%116.33M | -71.73%22.04M | 74.77%77.95M | 73.05%44.6M | -47.15%25.77M | --48.76M |
| Free cash flow | 116.82%13.09M | -28.29%-77.83M | -3,803.72%-60.67M | 106.88%1.64M | -14.71%-23.8M | -243.69%-20.75M | ---6.04M |
| Currency Unit | AUD | AUD | AUD | AUD | AUD | AUD | AUD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Heat List
US
Overall
Symbol
Price
% Chg
No Data
